by Team Small News | Apr 1, 2025 | Aurobindo Pharma, Divi's Laboratories, Pharma, Sun Pharma, Torrent Pharma, Zydus
Citibank has analyzed the potential impact of US tariffs on Indian pharmaceutical companies and has assigned a low probability to such an event. The brokerage firm simulated a 10% tariff scenario and found that companies with a high exposure to US generics, such as... by Team Small News | Apr 1, 2025 | Glenmark, Pharma
A UK High Court Judge, Michael Tappin, has rejected a request by AstraZeneca (AZ) and AstraZeneca UK Ltd. for an interim injunction to block Glenmark Pharmaceuticals Europe from launching a generic version of AZ’s diabetes drug, Forxiga. The generic version,... by Team Small News | Mar 31, 2025 | Pharma
The company’s board of directors has approved a modification to a previously announced slump sale transaction. As part of this modification, LUPINLIFE Consumer Healthcare Ltd. will now acquire an additional brand, in addition to the existing OTC business, on a...
by Team Small News | Mar 31, 2025 | Pharma, Zydus
Zydus Trust, a private charitable trust, has acquired a luxury flat in Mumbai’s Worli area for Rs 2 billion (approximately $27 million USD). The property, which spreads over 10,000 square feet, is situated in the upscale Worli district of Mumbai, known for its...
by Team Small News | Mar 31, 2025 | Pharma, Sun Pharma
Sun Pharma Advanced Research Company (SPARC), a subsidiary of Sun Pharmaceutical Industries, has submitted an Investigational New Drug (IND) application to the United States Food and Drug Administration (USFDA) for its investigational product, SBO-154. SBO-154 is an... by Team Small News | Mar 30, 2025 | Apollo Hospital, Pharma
The Supreme Court of India has taken a stern stance on the alleged non-compliance of a lease agreement by Indraprastha Apollo Hospital in New Delhi. The hospital, run by Indraprastha Medical Corporation Limited (IMCL), was to provide free medical and other facilities...